K. C. Balaji, M.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

163 Ratings

K. C. Balaji, M.D.


Clinical Interests

Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4131
Department: 336-716-4131

Insurance Accepted »

Education & Training

  • M.B.,B.S., Madras Univ Faculty Of Medicine Madras-India, 1986
  • Residency, Surgery, Bronx-Lebanon Hosp Ctr, 1993
  • Residency, Urology, Univ Massachusetts Med Ctr, 1997
  • Fellowship, Urologic Oncology, Memorial Sloan Kettering Cance, 1999

Board Certifications

  • American Board of Urology, Urology
  • American Board of Urology, Urology


  • Soc Of Basic Urologic Research
  • Soc Of Urologic Oncology
  • American Urological Assn

NPI Number

  • 1558314484
K. C. Balaji, M.D.

Doctor Rating

4.5 out of 5

163 Ratings

K. C. Balaji, M.D.

Professor, Urology
Cancer Biology
Institute for Regenerative Medicine

Research Interests

Cell Communication; Proto-Oncogene Proteins c-abl; rab5 GTP-Binding Proteins; Stromal Cells; Epithelial Cells
More »

Contact Information

Academic: 336-716-5690 | Department: 336-716-4131

Recent Publications

Cell line modeling to study biomarker panel in prostate cancer. NickKholgh B, Fang X, Winters SM, Raina A, Pandya KS, Gyabaah K, Fino N, Balaji KC.. Prostate. 2016;76(3):245-258.

E-cadherin facilitates protein kinase D1 activation and subcellular localization. Li Z, Zhang C, Chen L, Li G, Qu L, Balaji KC, Du C.. J Cell Physiol. 2016;231(12):2741-2748.

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Stuart CH, Singh R, Smith TL, D'Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH.. Nanomedicine (Lond). 2016;11(10):1207-1222.

The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2. Gmeiner WH, Boyacioglu O, Stuart CH, Jennings-Gee J, Balaji KC.. Prostate. 2015;75(4):360-369.

Novel in vivo model for combinatorial fluorescence labeling in mouse prostate. Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC.. Prostate. 2015;75(9):988-1000.

Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience [editorial comment]. Balaji KC.. J Urol. 2015;193(6):1916-1917.

Differential expression of novel PKD1 related biomarker panel in African American men with prostate cancer [abstract]. Nickkholgh B, Fang XL, Winters SM, Fino N, Balaji KC.. Cancer Res. 2015;75(15 Suppl):4342.

Autophagy: friend or foe for progression and treatment of urothelial carcinoma [editorial]. Balaji KC.. J Urol. 2014;191(6):1644-1645.

Prorainbow: a novel in vivo prostate mouse model to track the origin of prostate cancer [abstract]. Wicks EE, Fang XL, Balaji KC.. Tissue Eng Part A. 2014;20(Suppl 1):S139-S140.

Biological basis of aggressive phenotype in African-American prostate cancer cell line [abstract]. Nickkholgh B, Fang XL, Gyabaah K, Balaji KC.. Cancer Res. 2014;74(19 Suppl):A4000.

Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK.. J Endourol. 2013;27(8):1046-1050.

Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC.. PLoS One. 2013;8(9):e75187.

Novel 3D co-cultural model for epithelial-stromal cells interaction in prostate cancer [abstract]. Fang XL, Sivanandane S, Gyabaah K Balaji KC.. Cancer Res. 2013;73(8 Suppl 1):A4078.

Metastatic potential of a renal mass according to original tumour size at presentation [editorial comment]. Balaji KC.. BJU Int. 2012;109(2):194.

Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network. Du C, Zhang C, Li Z, Biswas MHU, Balaji KC.. PLoS ONE. 2012;7(4):e33830.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Urology

Clinical Interests

Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery
K. C. Balaji, M.D.

K. C. Balaji, M.D.

Professor, Urology
Cancer Biology
Institute for Regenerative Medicine

Doctor Rating

4.5 out of 5

K. C. Balaji, M.D.163 Ratings


Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
CP efforts to include in decisions
CP explanations of prob/condition
CP spoke using clear language
Friendliness/courtesy of CP
Likelihood of recommending CP
Patients' confidence in CP
Time CP spent with patient
Wait time at clinic

Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.


A professional in discussing my situation.


A wonderful doctor.


The doctor explain my condition to me and told me what he think we should do. He ask who I felt about it or did I have any question about what he had said. I like it when the doctor let the patient has a voice in their care


Everything OK.


Dr. Balaji was very good explaining the treatments options and prognosis for what could have been, and often is, a a fatal disorder. I have a great deal of confidence in and respect for Dr. Balaji.


*Dr. Balaji is so good & competent that I travel 5 hours to & 5 hours from _____ for his outstanding medical care! He is in the top order of physicians!! #5. No meds.


I drive 5 hours to see dr balaji. he's the best


While I realize Dr. Balaji has many patients to see, I have never felt that he was rushing to finish nor has he ever made any type of comment that would indicate he was rushed. As well as being professional in his approach, Dr. Balaji and the nursing staff always demonstrate an interest in my personal life, well-being and my quality of life as a human being. I appreciate they demonstrating a caring that is sincere not just appearing to be sincere.


#1. *K. Balaji


confidence in this doctor


*Dr. Balaji is an excellent doctor! I have all the faith in world in this man!!


Feel blessed that I was under the care and surgical knowledge of Dr. Balaji


All good.


Before seeing my doctor I had an ultrasound of my kidneys. Everyone was professional, pleasant and attentive.


everything good


I trust Dr. BValaji implicity.




In my opinion: If *Dr. Baliji doesn't walk on water, he knows where the rocks are.



Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.